Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCML Microcircuits Regulatory News (CML)

Share Price Information for CML Microcircuits (CML)

Share Price is delayed by 15 minutes
Get Live Data
287.50    -17.50 (-5.74%)
Bid:
280.00
Ask:
295.00
Spread: 15.00 (5.357%)
Market Cap: £47.89m
CML Live PriceLast checked at - London Stock Exchange

Intraday CML Microcircuits Share Chart

Share Buyback Programme

3 Oct 2022 07:00

RNS Number : 4485B
CML Microsystems PLC
03 October 2022
 

3 October 2022

CML Microsystems Plc

("CML" or the "Company")

 

Share Buyback Programme

 

CML is pleased to announce the launch of a share buyback programme of up to £1.0 million (the "Programme").

The Company has shareholder authority to repurchase 2,386,000 ordinary shares of 5 pence each ("Ordinary Shares") as approved at its last AGM (which represents c.15 per cent. of the Company's issued ordinary share capital). The Board has decided to launch the Programme to return funds to shareholders.

The maximum daily number of Ordinary Shares that will be purchased is 1,579, which is 25% of the average daily volume traded in September 2022, the month prior to this announcement. The Programme is currently expected to end no later than 12 months from the date of this announcement and in order to continue past the Company's 2023 AGM, which is typically held in August each year, a new shareholder authority will need to be obtained at the AGM for the Company to purchase its own shares. The principal purpose of the Programme is to reduce the share capital of the Company and return funds to shareholders who sell their Ordinary Shares; repurchased Ordinary Shares may be taken into treasury or cancelled.

In order to effect the Programme, the Company has entered into an agreement with the its broker, Shore Capital Stockbrokers Limited ("Shore Capital"), to carry out on-market purchases of its Ordinary Shares. This agreement includes provisions giving Shore Capital authority to carry out market purchases under the Programme independently of the Company.

The Programme will be conducted within the safe harbour parameters of the Market Abuse Regulation 596/2014/EU and the Commission Delegated Regulation 2016/1052/EU (each as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018, including where relevant pursuant to the Market Abuse (Amendment) (EU Exit) Regulations 2019) and Chapter 12 of the Listing Rules. The Company confirms that it currently has no other unpublished price sensitive information. Details of all purchases made pursuant to the Programme will be announced via RNS and published on the Company's website as required by the Market Abuse Regulation.

Enquiries:

CML Microsystems Plc

Chris Gurry, Group Managing DirectorNigel Clark, Executive Chairman 

 

  www.cmlmicroplc.com Tel: +44(0)1621 875 500

Shore Capital (Nominated Adviser and Broker)

Advisory Toby GibbsJames ThomasJohn More 

Corporate Broking Fiona Conroy

 

 Tel: +44(0)20 7408 4090 

Alma PR

Josh RoystonAndy BryantMatthew Young

 Tel: +44 (0)20 3405 0212

 

 

UK MAR: This announcement is released by the Company and contains information that qualified or may have qualified as inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 ("MAR") as it forms part of UK domestic law by virtue of the EUWA ("UK MAR"), encompassing information relating to the trading performance of the Company. For the purposes of UK MAR and Article 2 of the binding technical standards published by the Financial Conduct Authority in relation to MAR as regards Commission Implementing Regulation (EU) 2016/1055, this announcement is made by Chris Gurry, Group Managing Director.

About CML Microsystems PLC

CML develops mixed-signal, RF and microwave semiconductors for global communications markets. The Group utilises a combination of outsourced manufacturing and in-house testing with trading operations in the UK, Asia and USA. CML targets sub-segments within Communication markets with strong growth profiles and high barriers to entry. It has secured a diverse, blue chip customer base, including some of the world's leading commercial and industrial product manufacturers.

The spread of its customers and diversity of the product range largely protects the business from the cyclicality usually associated with the semiconductor industry. Growth in its end markets is being driven by factors such as the appetite for data to be transmitted faster and more securely, the upgrading of telecoms infrastructure around the world and the growing prevalence of private commercial wireless networks for voice and/or data communications linked to the industrial internet of things (IIoT).

The Group is cash-generative, has no debt and is dividend paying.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFSLFIFEESESS
Date   Source Headline
6th Dec 20227:00 amRNSTransaction in Own Shares
5th Dec 20227:00 amRNSTransaction in Own Shares
29th Nov 20229:32 amRNSTransaction in Own Shares
28th Nov 20227:00 amRNSTransaction in Own Shares
23rd Nov 20227:00 amRNSTransaction in Own Shares
22nd Nov 20227:00 amRNSHalf-year Report
22nd Nov 20227:00 amRNSTransaction in Own Shares
21st Nov 20227:00 amRNSTransaction in Own Shares
18th Nov 20227:00 amRNSTransaction in Own Shares
16th Nov 20227:00 amRNSTransaction in Own Shares
15th Nov 20227:00 amRNSTransaction in Own Shares
14th Nov 20229:29 amRNSTransaction in Own Shares
11th Nov 20227:00 amRNSTransaction in Own Shares
10th Nov 20227:00 amRNSTransaction in Own Shares
9th Nov 20227:00 amRNSTransaction in Own Shares
7th Nov 20227:00 amRNSTransaction in Own Shares
4th Nov 20227:00 amRNSTransaction in Own Shares
2nd Nov 20227:00 amRNSTransaction in Own Shares
1st Nov 20227:00 amRNSTransaction in Own Shares
31st Oct 20229:45 amRNSTransaction in Own Shares
28th Oct 20227:00 amRNSTransaction in Own Shares
27th Oct 20227:00 amRNSTransaction in Own Shares
26th Oct 20227:00 amRNSTransaction in Own Shares
25th Oct 20227:00 amRNSTransaction in Own Shares
24th Oct 20227:00 amRNSTransaction in Own Shares
21st Oct 20227:00 amRNSTransaction in Own Shares
20th Oct 20227:00 amRNSTransaction in Own Shares
19th Oct 20227:00 amRNSTransaction in Own Shares
18th Oct 20227:00 amRNSTransaction in Own Shares
17th Oct 20227:00 amRNSTransaction in Own Shares
17th Oct 20227:00 amRNSTransaction in Own Shares
14th Oct 20227:00 amRNSTransaction in Own Shares
13th Oct 20229:43 amRNSTransaction in Own Shares
7th Oct 20227:00 amRNSTransaction in Own Shares
3rd Oct 20227:00 amRNSShare Buyback Programme
28th Sep 20227:00 amRNSTrading Update and Notice of Results
26th Sep 202212:34 pmRNSBlock Listing Interim Return
26th Sep 20227:00 amRNSCML plans for new business hub at Oval Park
10th Aug 20224:02 pmRNSResult of AGM
10th Aug 20227:33 amRNSAGM Statement and Trading Update
3rd Aug 20223:00 pmRNSTransaction in Own Shares and Total Voting Rights
27th Jul 202212:38 pmRNSPosting of Annual Report and Notice of AGM
21st Jul 202210:20 amRNSHolding(s) in Company
18th Jul 20224:30 pmRNSDirector/PDMR Shareholding
18th Jul 20224:30 pmRNSHolding(s) in Company
18th Jul 20224:30 pmRNSHolding(s) in Company
18th Jul 20224:30 pmRNSHolding(s) in Company
5th Jul 20227:00 amRNSFull Year Results
10th Jun 20221:18 pmRNSChange to final results announcement date
27th Apr 20223:09 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.